Improving Parental Support in Hypospadias Care
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 12, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Improving Parental Support in Hypospadias Care" aims to enhance the way parents and children receive care for a condition called hypospadias, which affects the urinary opening in boys. In this study, parent-child pairs will be divided into different groups to test new methods of support over a period of 36 months. Each family will participate for at least six months and will be asked to attend a urology consultation to learn more about the child’s condition.
To be eligible for this study, parents must be at least 18 years old, speak and read either English or Spanish, and have access to a smartphone, tablet, or computer with reliable internet. They should also be the legal guardian of a child aged 0-5 years who has been referred to a urologist for a possible diagnosis of hypospadias. Families will not be able to participate if they have previously been in another hypospadias study or if the child has had prior surgery for this condition. Participants can expect to work with researchers who are dedicated to improving care and support for families dealing with hypospadias.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- A parent must meet all of the following criteria to be included:
- • Age ≥ 18 years old
- • Fluent and literate in English or Spanish
- • Parent or legal guardian
- • Ability to consent
- • One eligible parent per child
- • Plan to attend urology consultation
- • Has access to a smart phone, tablet, or computer with reliable internet access
- • Has the ability and agrees to receive unencrypted communications by text or email
- A child must meet all of the following criteria to be included:
- • 0-5 years old at the time of urology consultation
- • Referred to a urologist participating in the study for a new potential diagnosis of hypospadias
- • Exclusion Criteria
- If a parent meets any of the following criteria they will be excluded:
- • Previous participant in hypospadias study
- • Parent has another child with hypospadias or father of the child has a known history of hypospadias
- • Parent is unaware of any penile abnormality with child
- • Investigator discretion
- If a child meets any of the following criteria they will be excluded:
- • Prior hypospadias surgery
- • Initial hypospadias urology consult scheduled less than a week away from when the patient was identified
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Samantha Schilling, MD, MSHP
Principal Investigator
UNC Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported